Literature DB >> 20479289

The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.

Matthew Ndonwi1, Elodee A Tuley, George J Broze.   

Abstract

Protein S (PS) enhances the inhibition of factor Xa (FXa) by tissue factor pathway inhibitor-alpha (TFPI-alpha) in the presence of Ca(2+) and phospholipids. Altered forms of recombinant TFPI-alpha were used to determine the structures within TFPI-alpha that may be involved in this PS-dependent effect. Wild-type TFPI-alpha (TFPI(WT)), TFPI-alpha lacking the K3 domain (TFPI-(DeltaK3)), and TFPI-alpha containing a single amino acid change at the putative P1 residue of K3 (R199L, TFPI(K3P1)) produced equivalent FXa inhibition in the absence of PS, whereas the response in FXa inhibition produced by PS was reduced with TFPI(K3P1) (EC(50) 61.8 +/- 13.4nM vs 8.0 +/- 0.4nM for TFPI(WT)) and not detectable with TFPI-(DeltaK3). Ligand blotting and surface plasmon resonance experiments demonstrated that FXa bound TFPI(WT) and TFPI-(DeltaK3) but not the isolated K3 domain, whereas PS bound TFPI(WT) and the K3 domain but not TFPI-(DeltaK3). Addition of TFPI(WT), TFPI(K3P1), or TFPI-(DeltaK3) produced comparable prolongation of FXa-induced coagulation in PS-deficient plasma, but the anticoagulant effect of TFPI(WT) was substantially greater than that of TFPI(K3P1) > TFPI-(DeltaK3) in normal plasma and PS-deficient plasma reconstituted with PS. We conclude that the PS-mediated enhancement of FXa inhibition by TFPI-alpha involves an interaction between PS and TFPI-alpha, which requires the K3 domain of TFPI-alpha.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20479289      PMCID: PMC2938241          DOI: 10.1182/blood-2009-10-246686

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Self-association of human protein S.

Authors:  J E Pauls; M F Hockin; G L Long; K G Mann
Journal:  Biochemistry       Date:  2000-05-09       Impact factor: 3.162

2.  Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C.

Authors:  S P Leytus; D C Foster; K Kurachi; E W Davie
Journal:  Biochemistry       Date:  1986-09-09       Impact factor: 3.162

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

5.  Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity.

Authors:  K M Seré; M P Janssen; G M Willems; G Tans; J Rosing; T M Hackeng
Journal:  Biochemistry       Date:  2001-07-31       Impact factor: 3.162

Review 6.  Blood coagulation.

Authors:  C M Jackson; Y Nemerson
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

7.  Concentrations of binding protein and labeled analyte that are appropriate for measuring at any analyte concentration range in radioimmunoassays.

Authors:  C J Halfman
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

8.  Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor.

Authors:  Jing Zhang; Orlando Piro; Lan Lu; George J Broze
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

9.  The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.

Authors:  G J Broze; L A Warren; W F Novotny; D A Higuchi; J J Girard; J P Miletich
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

10.  Kinetics of factor Xa inhibition by tissue factor pathway inhibitor.

Authors:  Z F Huang; T C Wun; G J Broze
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

View more
  34 in total

1.  TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes.

Authors:  Thomas J Girard; Elodee Tuley; George J Broze
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

2.  Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder.

Authors:  George J Broze; Thomas J Girard
Journal:  J Clin Invest       Date:  2013-08-27       Impact factor: 14.808

3.  Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.

Authors:  T J Girard; K Grunz; N M Lasky; J P Malone; G J Broze
Journal:  J Thromb Haemost       Date:  2018-10-22       Impact factor: 5.824

4.  Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor.

Authors:  Cristina Puy; Erik I Tucker; Anton Matafonov; Qiufang Cheng; Keith D Zientek; Dave Gailani; András Gruber; Owen J T McCarty
Journal:  Blood       Date:  2015-01-13       Impact factor: 22.113

Review 5.  Platelets: Context-Dependent Vascular Protectors or Mediators of Disease.

Authors:  Randal Westrick; Gabrielle Fredman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07       Impact factor: 8.311

Review 6.  Controlling coagulation dysregulation in xenotransplantation.

Authors:  Peter J Cowan; Simon C Robson; Anthony J F d'Apice
Journal:  Curr Opin Organ Transplant       Date:  2011-04       Impact factor: 2.640

7.  Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo.

Authors:  Dongying Ma; Daniella M Mizurini; Teresa C F Assumpção; Yuan Li; Yanwei Qi; Michail Kotsyfakis; José M C Ribeiro; Robson Q Monteiro; Ivo M B Francischetti
Journal:  Blood       Date:  2013-10-24       Impact factor: 22.113

8.  An acquired, calcium-dependent, factor X inhibitor.

Authors:  George J Broze
Journal:  Blood Cells Mol Dis       Date:  2013-09-26       Impact factor: 3.039

9.  Endogenous tissue factor pathway inhibitor in vascular smooth muscle cells inhibits arterial thrombosis.

Authors:  Jichun Yang; Kaiyue Jin; Jiajun Xiao; Jing Ma; Duan Ma
Journal:  Front Med       Date:  2017-05-27       Impact factor: 4.592

Review 10.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.